Tyra Biosciences Inc

Research Tyra Biosciences Inc (TYRA) on Bullrun: market cap USD 1.91B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTYRA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.91B
• Financial periodFY2025
• Net income-USD 119.95M
• Free cash flow-USD 95.28M

Valuation Snapshot

latest market cap is USD 1.91B.

About Tyra Biosciences Inc

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.

Frequently asked questions

What is Tyra Biosciences Inc's market cap?

Tyra Biosciences Inc's market capitalization is USD 1.91B.

What does Tyra Biosciences Inc do?

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.